Related Experiment Video
Updated: Jun 24, 2026

Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
Microbiome-Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers
Atsunari Kawashima1, Kentaro Jingushi2, Takuro Saito3
1Department of Urology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
The gut microbiome influences genitourinary cancers like urothelial carcinoma and renal cell carcinoma. Circulating microbial signals in extracellular vesicles may predict immunotherapy response.
Area of Science:
- Microbiology
- Oncology
- Immunology
Background:
- The microbiome's role in cancer is established in some cancers but less defined in genitourinary (GU) cancers.
- Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, with microbiome influencing response.
Purpose of the Study:
- To review the influence of microbiome-related pathways on urothelial carcinoma (UC) and renal cell carcinoma (RCC).
- To explore the connection between gut microbial environments, carcinogenesis, and ICI outcomes in GU cancers.
Main Methods:
- Review of preclinical studies using N-butyl-N-(4-hydroxybutyl) nitrosamine mouse models for urothelial carcinogenesis.
- Analysis of emerging clinical data on circulating extracellular vesicle (EV)-associated bacterial DNA in UC and RCC patients.
Main Results:
- Preclinical models demonstrate gut microbiota can causally affect urothelial carcinogenesis via metabolism and inflammation.
- Circulating EV-associated bacterial DNA correlates with tumor immune phenotypes and ICI response in UC and RCC.
Conclusions:
- Microbiome-related signals link gut ecology, systemic immunity, tumor microenvironment, and treatment response in GU cancers.
- Circulating EV-associated bacterial DNA is a promising, albeit exploratory, biomarker platform for GU cancers and immunotherapy.
Related Concept Videos
Microbiota of the Urogenital Tract
Nursing Assessment of the Genitourinary System I: Health History
Introduction to the Human Microbiota
Urinary Tract Infection II: Pathophysiology
The Tumor Microenvironment
Dysbiosis of the Gut Microbiota

